Streamline OCT System is intended for use in the treatment of spinal stenosis, tumors, degenerative disc disease, and spondylolisthesis.
A degenerative eye disease slowly robbed Roger Pontz of his vision – but medical advancements is changing all of that.
GS1 Healthcare US releases implementation guideline for using GS1 standards to address FDA unique device identification (UDI).
Boston Scientific’s FDA approval of innovative new defibrillators and heart failure devices extends the company’s offerings.
Covidien gets U.S. Food and Drug Administration 510(k) clearance for the Kangaroo Feeding Tube with IRIS technology.
Kallik’s AMS360 software is proving vital for medical devices firms who need to meet critical compliance directives.
Approval positions Syneron with disruptive product offering in fast growing body contouring and fat treatment market.
CoreValve system enables physicians to treat patients with aortic stenosis who are unable to undergo surgery.
The Avance medical device system will be in limited market release in the Q2 & Q3 of 2014, and is planned for full launch in the Q4 of 2014.
Femoral hip prosthesis is intended for cementless use in total hip replacement and hemiarthroplasty procedures.
First-of-a-kind ultrasound system initially targeted for image-guided peripheral intravenous access (PIV); fits in clinicians' pocket.
Zimmer’s Optio-C system offers a no profile solution and delivers the strength, stability, and fusion potential of a traditional ACDF.
Innovative handle design enables physician preferences for precision, comfort, and control when acquiring tissue samples.
The FDA's new device pre-submission program: What does it mean for you?
Proposed health information technology strategy aims to promote innovation, protect patients, and avoid regulatory duplication.